CTIS.eu › Cities › France › Grenoble Cedex 9
Grenoble Cedex 9
France
563 total trials
252 recruiting
2024-512659-19-00
10
2025-03-31
Advanced Melanoma
2024-512733-32-00
5
2025-03-31
Acute Myeloid Leukemia (AML)
2023-507097-41-01
5
2025-03-20
Patients with limited-stage small cell lung cancer (LS-SCLC)
without
2023-507853-13-00
4
2025-02-25
Ulcerative Colitis
2024-514097-52-00
6
2024-12-16
Impact of inhaled BGF 160 on complexity and variability of tidal breat
2023-507746-83-00
5
2024-11-27
Generalized Myasthenia Gravis
2024-519113-59-00
4
2024-11-20
Hepatocellular carcinoma
2024-514799-42-00
4
2024-11-05
IDIOPATHIC PULMONARY FIBROSIS
2024-516394-78-00
5
2024-11-05
Patient with sepsis complicated by ARDS
2024-517004-11-00
5
2024-10-22
Chronic pulmonary aspergillosis
2023-504358-36-00
5
2024-10-17
multiple sclerosis
2023-507129-40-00
4
2024-08-06
interstitial lung disease secondary to systemic sclerosis (SSc-ILD)
2023-503699-25-00
5
2024-07-15
Progressive Pulmonary Fibrosis
2023-503697-21-01
5
2024-06-24
Idiopathic pulmonary fibrosis
2023-503545-67-00
5
2024-04-30
Tourette's Disorder
2023-508153-12-00
5
2024-03-26
Hospital-acquired pneumonia
2023-503523-25-00
4
2024-02-29
Non-small cell lung cancer
2023-505486-92-00
4
2024-02-09
Small bowel adenocarcinoma
2023-505604-32-00
5
2024-01-24
Non small cell lung cancer (NSCLC)
2023-505121-14-00
5
2024-01-18
Moderate to Severe Plaque Psoriasis
2023-504670-38-00
4
2023-11-17
Extensive disease Small Cell Lung Cancer
2022-502548-12-00
5
2023-09-28
marginal zone lymphoma
2022-502959-54-00
5
2023-09-26
Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring Ep
2022-501709-11-00
5
2023-06-06
Isocitrate deshydrogenase1 mutation-positive (IDH1m) acute myeloid leu
Showing 73–96 of 563 trials